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1. INTRODUCTION: Latent TGFbeta binding protein plays a critical role in positioning and activating TGFbeta, a protein with dual tumor suppressor and promoter functions at different stages of breast cancer. Latent TGFbeta is secreted into the extracellular matrix bound to LTBP, which then associates with fibronectin and fibrillin associated with elastin fibers. LTBP1 has not been studied in the mammary gland or breast cancer. The goal of this proposal is to test whether elevated LTBP1 expression induces metastasis. This hypothesis was formulated based on our data showing that LTBP1 is highly expressed during normal involution, a window of development associated with heightened risk of breast cancer and is elevated in signatures of cell lines selected for specific sites of metastasis. The Aims of this project are to examine LTBP1 expression in breast cancer and to test functionally the effect of modulating LTBP1 on breast cancer cell line behavior and in mouse models of breast cancer.
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ACCOMPLISHMENTS:
Ø What were the major goals of the project: Figures. 7a, b ) and localizing the secreted LTBP1 protein by immunofluorescence to the ductal encasement (Figures10 g and h, 11). The key findings of this study are that LTBP1 is dynamically regulated and will restrict TGFbeta activity to specific periductal locations and windows of development. We show that LTBP1 expression correlates with lumen formation and the emergence of the luminal cell fate. Importantly, it is produced exclusively by a subset of luminal cells (Figure 7 c-f) restricted to the permanent ductal system and provides a rare unique marker distinguishing ductal from alveolar luminal lineages. LTBP1 protein was found exclusively encasing the ductal system and is absent from terminal end buds and alveoli. The permanent ductal system, which harbors mammary stem cells, is encased by LTBP1 and elastin. In contrast the temporary mammary side branches are surrounded by LTBP1 but not elastin and alveoli lack both. Thus distinct segments of the mammary tree of differing function, fate and differentiation, stem cell content and longevity are associated with unique extracellular matrices. Importantly for this proposal we identified that LTBP1 mRNA and protein expression is maximal during involution. This developmental period involves the removal of temporary alveoli and side-branches following weaning and is associated with heightened breast cancer risk that is postulated to arise from the accompanying extensive matrix remodeling changes, which create a prometastatic microenvironment.
b) Task 1. Determine the expression of LTBP1 in human and mouse breast cancers and breast cancer cell lines (25% complete)
Luminal and basal breast cancer are both thought to arise from different types of luminal cells. Our preliminary and now published data, described above, show that ductal luminal cells produce LTBP. The significance of this for breast cancer is that it suggests that contrary to expectation, the seed of breast cancer produces and carries its own putative prometastatic soil.
The goal of Task 1 is to document LTBP1 expression in breast cancers and cell lines and correlate this with patient outcome. We proposed to examine a large number of human breast tumors, pregnancy associated breast cancers and a panel of breast cancer cell lines representative of the five major subtypes of human breast cancer.
To test our central hypothesis that increased LTBP1 is prometastatic we performed in silico analyses. To assess expression of Ltbp1 in breast cancer we began by mining in silico data using database available online specifically Kaplan-Meier plotter (kmplot.com), Breastmark (http://glados.ucd.ie/BreastMark/index.html) and Oncomine (www.oncomine.org) databases. High and low expression of Ltbp1 in total breast cancers and the different subtypes was correlated with Recurrence-Free and Distant Metastasis-Free Survival. High Ltbp1 was associated with poor survival outcomes using these datasets. To provide a basis from which to select the human breast cancers that we should focus on for our studies of LTBP1 we analyzed the outcome data broken down into the major subtypes of breast cancer. This analysis shows that high LTBP1 expression correlated significantly with recurrence in Basal and HER2 subtypes and showed only a modest difference in luminal A and B subtypes. Collectively these studies suggest that LTBP1 expression is most clinically relevant within the pathological setting of Basal and Luminal Her2-positive ER-negative breast Luminal Her2+
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cancers. These represent the breast cancers with the worst outcome and in the case of Basal breast cancer are the ones that are prevalent in young women of reproductive age.
In light of the findings above we plan to focus our efforts to detect LTBP1 expression on human Basal and Luminal HER2-positive ER-negative breast cancers and cell lines. In order to proceed with our plan to investigate LTBP1 protein expression and localization immunochemically in tissue microarrays of relevant human breast cancer samples it was necessary first to determine whether the available antibodies could detect human LTBP1 and to establish the conditions under which they work best. We have tested two antibodies, Ab39 and LIC, on frozen and paraffin embedded PFA-fixed normal breast samples derived from discarded reduction mammoplasty. We concurrently investigated the binding partner for LTBP1 by performing co-immunofluorescence for fibrillin 1 and elastin. Both antibodies localized LTBP1 in close proximity to the basal layer of human TDLU, similar to our findings in mice of LTBP1 encasing the mammary ducts. Both LTBP1 antibodies worked best on frozen sections. Elastin antibodies proved to be specific for mouse and did not stain human tissue, however elastin can be detected by histochemical stains as shown in figure 10 of our published paper. The fibrillin antibody worked well on human tissues specimens and showed robust expression next to the LTBP staining. Diffuse staining was observed with the LTBP1 antibodies on formalin-fixed and paraffin-embedded specimens. We are currently working on optimizing conditions that will permit reliable LTBP1 epitope retrieval in these samples as this will greatly facilitate the planned analysis of archival breast cancer specimens. In the meantime, we have requested the NYU biorepository core to retrieve and collect frozen and fixed samples of pregnancy associated breast cancer (see letter). We have also requested developmental stages of normal human breast development from the Susan G. Komen bank. These samples will allow us to confirm if elevated expression of LTBP1 occurs, as predicted form mouse studies, during normal involution and in PABC. 
Task 2 Determine the consequences on motility, invasion and metastasis of modulating LTBP1 level in breast cancer cell lines (30% complete).
Task 2a) Clone LTBP1 sequences into an appropriate expression vector, transfect human and mouse cell lines and assess LTBP1 expression by western analysis (months 10-18).
We have generated a cDNA of human LTBP1L and chosen to clone this into the lentiviral expression vector pHIV-Zsgreen, which has been successfully used to efficiently infect primary mammary epithelial cells as evidenced by GFP reporter expression. LTBP1 is a secreted protein, therefore to evaluate the extent of LTBP1 expression we have been optimizing LTBP1 detection within the conditioned media of breast cancer cell lines. As the antibodies recognize conformation-specific epitopes this requires SDS-PAGE analysis under non-reducing conditions. We now have these conditions established and are positioned to proceed to analyze the LTBP1-GFP-positive infected cell lines for their relative levels of secretion of LTBP.
Figure 5:
Shows the pHIV-LTBP1-ZsGreen expression construct (left) and detection of LTBP1 in the conditioned medium of breast cancer cell lines by western blotting under non-reducing SDS-PAGE conditions.
Task 2b) Clone short hairpin sequences of LTBP1 (shRNA) in lentiviral vectors, transfect into high LTBP1 expressing human (MDA-MB-231) and mouse (4T1) metastatic breast cell lines, and assess effective suppression by western analysis (months 10-18)
We have cloned two LTBP1 hairpins (sh1 within the coding region, sh2 in the 3'UTR and scrambled controls) into the lentiviral vector pLKO-GFP and pLKO-RFP respectively. We have tested their expression in the pLKO-GFP/RFP versions in MCF10A cells, which express LTBP1 robustly and found 75% infection rate as judged by reporter fluorescence (Figure 6 top panels). Both hairpins efficiently knocked down LTBP1 mRNA as assessed by RT-PCR ( Figure 6 bottom panels). We are currently testing the specificity of this shRNA knock down and controlling for off-target effects by rescuing LTBP1 mRNA expression by co-expression of human LTBP1 lacking the Ltbp1 3'UTR and pHIV-LTBP1-ZsGreen described above. Our next step will be to confirm this knock down at the protein level by western analysis. Once validated we aim next to infect the MDA-MB-231 and their more highly metastatic variant cells, which we have recently purchased from Dr. Juan Massague (MSKCC). Of note we have observed significant rounding and detachment of cells with strong reduction of both isoforms of LTBP1. This maybe biologically important and suggest a more fundamental role for LTBP1 in cell-matrix attachment. To explore the effects of LTBP1 knock down in a more quantitative way we have cloned both hairpins into a Tetracycline-regulatable form of the vector pLKO-Tet-On.
Task 3: Determine the pathological significance of gain and loss of LTBP1 in mice (25% complete). a) Generate the Ltbp1 transgenic mouse model (months 1-24)
So far we have cloned the MMTV-LTR into pGEM5z and introduced a cassette comprising the rabbit beta-globin gene and polyA sequence to stabilize transgene
expression. We are in the process of excising human LTBP1-GFP from pHIV-ZsGreen described above in Figure 2 and inserting this into the rabbit beta globin sequence.
b) Generate lentiviral particles for inducible overexpression and knockdown of
Ltbp1 (months 1-24) Lentiviral sh1 described above in Task 2b and Figure 6 has been designed to work in mouse as well as human cell lines.
c) Introduce lentiviral constructs into poorly MMTV-Neu/ErbB and highly metastatic MMTV-PyMT MECS and transplant into cleared fatpads.
We have purchased the the PyMT and MMTV-neu mice. These mice have been bred and a cohort maintained for tumor development as a source of primary tumor mammary epithelial cells that we can infect with lentiviral construct described in Figures 5 and 6 above and reintroduce into hosts to determine the effects of modulating LTBP1 on tumor progression.
Ø What opportunities for training and professional development has the project provided. Ø What do you plan to accomplish during the next reporting period to accomplish the goals and objectives 1. Determine conditions for epitope retrieval to permit LTBP1 detection in archival samples of breast cancer and collect fresh frozen samples from the biorepository. 
IMPACT
Ø What was the impact on the development of the principal discipline of the project.
Our results have highlighted the concept that the actions of the breast tumor suppressor and metastasis promoter TGFbeta are spatially and temporally restricted in a very dynamic spatio-temporal pattern during breast development and are not, as thought previously, ubiquitously available to all mammary cells. This means TGFbeta activity in terms of signaling within responding cells is very tightly controlled by LTBP1 expression. Our data also reveal that fibrillin and elastin are expressed at significant levels within breast stroma. There are no studies on LTBP1, fibrillin or elastin in breast so this has opened up a new field of study in stromal composition of the breast.
Our unpublished data reported herein indicat that LTBP1 expression has value as a prognostic indicator of patient outcome in HER2 and Basal type breast cancer.
Ø What was the impact on other disciplines The expression pattern of LTBP1 suggests it may play a critical role in regulating epithelial stem cell quiescence and survival that could be relevant in many epithelial tissues and cancers.
Ø What was the impact on technology transfer
Nothing to report Ø What was the impact on society beyond science and technology Nothing to report as yet but linking breast development factor to breast cancer risk opens the door to preventative strategies linked to reproductive history.
CHANGES/PROBLEMS
Ø Delays in approach and reasons for delay Nothing to report Ø Actual anticipated problems or delays and actions or plans to resolve them -Nothing to report Ø Changes that had a significant impact on expenditures -There was a delay in hiring a suitable postdoctoral fellow.
Ø Significant changes in use or care of human subjects, animals, biohazards or select agents -Nothing to report
PRODUCTS Ø Publications, conference papers and presentations • Journal Publications:
Author: Chandramouli Ø What other organizations were involved as partners? Regeneron Inc. Tarrytown, NY G. Droguett and D. Frendewey performed qPCR analysis of LTBP1 expression for us using RNA samples from our laboratory for the published paper below. Ltbp1L is focally induced in embryonic mammary mesenchyme, demarcates the ductal luminal lineage and is upregulated during involution Chandramouli et al.
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Introduction
Latent transforming growth factor β (TGFβ) binding proteins (LTBPs) are regulators of elastogenesis and TGFβ [1] . Their critical role in tissue development, homeostasis and resilience is demonstrated by the fact that LTBP lossof-function mutations underpin a growing list of human genetic syndromes [2] [3] [4] . Gain of LTBP gene expression also has pathological consequences: LTBP1 is upregulated in two breast cancer metastasis signatures and is one of only six genes found in common to both [5, 6] .
Ltbp genes encode a family of secreted proteins, Ltbp1-4, that show extensive sequence homology to fibrillins, which polymerize to form microfibrils and coat elastic fibers [1, 7] . Ltbp proteins are initially deposited onto fibronectin and later transferred to microfibrils by interaction with fibrillins [8] . Their importance for the structural integrity and tensile function of the extracellular matrix (ECM) is illustrated by the pathologies seen in Ltbp4S-null mice resulting from defective elastic-fiber formation in the intestine, lung and pulmonary artery and in humans with Urban-Rifkin-Davis syndrome [4, 9, 10] .
In addition to their contribution to ECM structure, Ltbp1, Ltbp3 and to a lesser extent Ltbp4 govern the spatial patterning and activation of TGFβ. TGFβs are secreted in a latent form, encapsulated by their cleaved latency-associated propeptide (LAP), and deposited within the ECM for subsequent activation. Ltbps post- The Ronald O Perelman Department of Dermatology, New York University School of Medicine, 550 First Ave, New York, NY 10016, USA Full list of author information is available at the end of the article translationally regulate TGFβ in three ways. First, they chaperone the association of TGFβ with LAP and through preferential binding affinities control which of three TGFβ isoforms emerge from the cell [11] . Second, Ltbps incorporate latent TGFβ within the ECM thereby determining where TGFβ is presented to its receptors [12] . Third, Ltbps provide a key link between the ECM and the cell surface that is essential for stretch activation of TGFβ [13] [14] [15] . Both integrins and Ltbp bind to LAP. Thus, when Ltbp1 is anchored in a stiff ECM and stress fibers exert tension on integrins, conformational changes occur in LAP that lead to release of the active TGFβ [13, 14, 16] . One major response to TGFβ signaling is synthesis of new matrix proteins [17] . Thus, Ltbps create a mechanosensory system that generates a highly localized feedback response to cell traction or tension within the microenvironment [1, 18] .
Mouse mutants have illuminated the roles of Ltbps in tissue homeostasis and their involvement in human pathology. Ltbp1 hypomorphs show facial dysmorphia [19] and Ltbp1L loss leads to embryonic lethality due to heart malformation [20] , Ltbp2 loss-of-function mutations cause glaucoma in humans and lens defects in mice [21] , Ltbp3 loss-of-function mutation results in severe bone malformation [3, 22, 23] and Ltbp4S-null mice show multiple organ defects [4, 9, 10] . In some mutants the prevailing pathology reflects compromised elastogenesis [10, 24] . In others the phenotype can be ameliorated by concurrent deletion or pharmacological antagonism of TGFβ, supporting the central role of Ltbps in TGFβ biology and pathology [10] .
Three TGFβ isoforms are differentially expressed and exert multiple effects during mammary development [25] . Loss-and gain-of-function studies have shown that TGFβ signaling restrains pubertal ductal extension and side branching by stimulating Wnt5a expression [26] [27] [28] [29] [30] [31] . TGFβ1 influences stem cell regenerative potency and cell-fate determination and has been proposed to suppress precocious alveologenesis in the adult gland prior to pregnancy [27, [32] [33] [34] [35] [36] . Weaning massively induces TGFβ3 expression, and this surge is essential for the demise of the differentiated glandular epithelium and remodeling events during mammary involution [37, 38] . TGFβ1 has also been the object of intense investigation due to its pathological relevance for breast cancer [39, 40] where it acts as a tumor suppressor in premalignant lesions and at later stages promotes metastasis through induction of epithelial-to-mesenchymal transition (EMT).
Knowledge of Ltbp's temporal and spatial expression pattern is central to understanding TGFβ signaling both in the physiological setting of the normal mammary gland and in breast cancer. Yet to date there have been no studies on Ltbp within the normal mammary gland.
Here we show that Ltbp1 is induced in a highly specific temporal and spatial pattern throughout mammary development, supporting the concept that dynamic transcriptional regulation of Ltbp1 provides a mechanism to impose considerable restriction on TGFβ bioavailability. Ltbp1L is upregulated early during embryonic mammary mesenchyme specification and is sustained in smooth muscles of the nipple sphincter. Within the mammary gland, Ltbp1L is induced exclusively in the ductal luminal epithelium but is silent in alveoli and therefore provides a rare biomarker distinguishing ductal from alveolar luminal lineages. Ltbp1 protein is deposited around basal cells of all ducts and side branches, and lies in close proximity to elastic fibers that exclusively encase the permanent ductal system. Ltbp1 is prominently upregulated during involution, with kinetics similar to that reported for TGFβ3, suggesting important functions in gland remodeling.
Methods
Mice
Ltbp1L lz/+ mice, were generated by Regeneron Pharmaceuticals, Inc., Tarrytown, NY. VelociGene methods [41] were used to recombineer a bacterial artificial chromosome (BAC) clone, such that a region extending from the 165th codon of murine Ltbp1L in exon 2 through the remainder of exon 2 and 7.8 kb into the downstream intron, was replaced by homologous recombination with an expression cassette comprising the transmembrane domain of ROR1 fused in-frame with the upstream coding sequence of Ltbp1L, followed by a stop-transfer sequence, a modified β-galactosidase coding sequence (lacZ), a polyadenylation signal and an antibiotic selection cassette flanked by loxP sites [42] (see Figure 1 ). The modified BAC, was linearized, producing 5′ and 3′ homology arms of approximately 150 kb and 30 kb flanking the deletion, and electroporated into SvEv129/C57Bl6/F1-derived hybrid embryonic stem (ES) cells. Targeting of ES cells and the germline transmission were confirmed by a quantitative reverse transcriptase PCR (qRT-PCR) assay that scored for the loss of one of the native Ltbp1L alleles [41] . The neo R cassette was removed by crossing with mice expressing Cre recombinase in the germ-cell lineage and the knockout was confirmed by northern and western analysis [20] . Ltbp1L lz/+ mice on a mixed C57Bl6/129 background were rederived into the Skirball animal facility and crossed onto an FVBN strain background by breeding through nine generations. All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of New York University School of Medicine.
Carmine staining of mammary whole mounts revealed no differences between Ltbp1L lz/+ mice and wild-type littermates in ductal elongation, branching, alveolar development or involution. Pups from both genotypes faired equally well in terms of weight gain (data not shown). We concluded that Ltbp1L lz/+ mice show no evidence of haploinsufficiency and justified their use to study the regulated expression of Ltbp1L during mammary development. Staging of pregnancy and embryos were performed by daily checking of vaginal plugs, with noon of the day of the plug considered day 0.5. Embryonic stages were confirmed by determining the degree of limb development as indicated in Theiler's classification of mouse development (The Atlas of Mouse Development, MH Kaufman).
Genotyping
Mice and embryos were screened by 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-Gal) staining of tails and confirmed by PCR analysis. Genomic DNA was prepared from 0.5 cm of tail by digesting overnight in 0.5 ml digestion buffer (50 mM Tris-HCl pH 7.4, 100 mM ethylenediaminetetraacetic acid (EDTA), 100 mM NaCl, 0.5% SDS, 200 μg/ml proteinase K). Then 150 μl of 5 M NaCl was added and the digest was agitated for 15 minutes on a rotator: 500 μl of supernatant was collected after centrifugation at 14,000 G for 15 minutes, and subjected to two rounds of ethanol precipitation. The final pellet was resuspended in 200 μl TE (10 mM Tris-HCl pH 7.4, 1 mM EDTA) and 1 μl was added to a 20-μl PCR. Thirty cycles of PCR (94°C, 58°C and 72°C for 1 minute each) were carried out. The wild-type Ltbp1L allele was detected by amplification of a 430-bp band using forward 5′-CT TAGTTCCTCCATCCTTCC-3′ and reverse 5′-CAGA CTTCACCTTCCCAGGG-3′ primers. The Ltbp1L lz/+ knock-in allele was detected in a separate reaction using the forward primer listed above and a reverse primer 5-GTCTGTCCTAGCTTCCTCACTG-3′ (see Figure 1B arrowheads) to amplify a 440-bp product. The gender of embryos was determined by amplification of the Sry gene on the Y chromosome (forward primer: 5′-GAGAGCATG GAGGGCCAT-3′ and reverse primer: 5′-CCACTCCTC TGTGACACT-3′). Amplification products were resolved by electrophoresis on 2% agarose gels run for 30 minutes in TAE electrophoresis buffer (40 mM Tris-acetate, 1 mM EDTA).
X-Gal staining of embryos and mammary gland whole mounts
Embryonic day (E) 10.0 to E15.5 embryos were dissected and fixed in 4% paraformaldehyde (PFA) (Sigma Aldrich, St Louis, MO, USA) prepared in PBS for 20 to 50 minutes depending on the stage. Skin with attached mammary fat pads was removed from E16.5 to E18.5 embryos and stretched carefully on cardboard, and mammary glands from adult mice were dissected and flattened onto glass slides then fixed in 4% PFA for 30 minutes. Following fixation, samples were washed 4 × 15 minutes with rinse buffer (2 mM MgCl 2 , 0.1% sodium deoxycholate, 0.2% NP40 prepared in PBS) and stained in X-Gal staining solution (5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mg/ml 5-bromo-4chloro-3-indolyl-b-D-galactopyranoside (X-Gal, Denville Scientific, South Plainfield, NJ, USA) prepared in rinse buffer) at room temperature for 2 to 3 h. After staining, samples were rinsed twice in PBS and post-fixed in 4% PFA overnight at 4°C, dehydrated through an ethanol gradient (2 × 10 minutes in 70%, 95%, and 100% ethanol), then placed in Carnoys's fixative (60% ethanol, 30% chloroform, 10% glacial acetic acid) followed by Citrisolv reagent (Fisher Scientific, Pittsburgh, PA, USA) to clear the fat.
Whole-mount carmine staining X-Gal stained mammary glands were rehydrated in a reverse-graded series of ethanol washed in water and then stained for 1 h in carmine solution diluted 1:5 in water. Carmine was prepared by boiling 1 g carmine alum and 2.5 g aluminium potassium sulphate in 500 ml of water for 20 minutes followed by filtration. The glands were dehydrated in a graded ethanol series, cleared in Carnoy's solution, placed in Citrisolv for 30 minutes, and mounted in Cytoseal (VWR, Radnor, PA, USA). Glands were then viewed using a Zeiss Axiovert (Oberkochen, FRG) brightfield microscope.
Histology and immunodetection E10.5-stage embryos were embedded in 10% gelatin, sectioned at 70 μm with a vibratome, and mounted with Fluoromount G (Southern Biotech, Birmingham, AL, USA). Older embryos and mammary glands were processed for X-Gal staining and fixation as described above.
Isopropanol was substituted for xylene to prevent diffusion of the X-Gal stain during processing and tissues were embedded in paraffin and sectioned. Sections (4 μm) were placed on Superfrost Plus slides, baked 1 h at 60°C and deparaffinized for 5 minutes in Citrisolv for X-Gal-stained tissues. Tissues were then rehydrated through a reverse gradient of ethanol solutions. For histology, sections were stained with 0.1% solution of Nuclear Fast Red (NFR) (Polyscientific, Bayshore, NY, USA) for 1 minute. Tissues were then dehydrated and dipped in xylene (or Citrisolv in the case of X-Gal-stained tissues) before being mounted in Cytoseal (VWR). For immunohistochemistry (IHC), citric acid antigen retrieval was performed by submerging the slide containing deparaffinized 4-μm sections in 10 mM sodium citrate solution (pH 6.0) and boiling in a microwave at 90% power for 30 minutes, followed by quenching of endogenous peroxidase using 3% hydrogen peroxide. 
Mammary epithelial cell preparation and flow cytometry
The third, fourth and fifth mammary glands from 8-to 16-week-old virgins were dissected, inguinal lymph nodes were discarded, and the mammary glands were minced between two scalpels into a fine paste. The tissue was dissociated for 6 h at 37°C in collagenase/hyaluronidase solution (catalog number 07912, Stem Cell Technologies Inc., Vancouver, BC, Canada), and further dissociated with 0.25% Trypsin-EDTA and 10 mg/ml dispase (catalog number 07913, Stem Cell Technologies) with 1 mg/ml DNase, before filtering through a 40-μm mesh. Endothelial and hematopoietic lineages were depleted using antibodies to TER119, CD45, CD140a, and CD31 ( 
RNA isolation and qRT-PCR analysis
The fourth and fifth pair of mammary glands were harvested from wild-type mice at different stages of postnatal mammary development, dissected and snap-frozen in liquid nitrogen. A block of tissue approximately 0.5 × 0.5 × 0.5 cm was homogenized for 5 minutes in 1 ml of TRI-Reagent (Life Technologies) using a hand-held tissue (custom assay with forward primer: 5′-TTCCAAGGCAA GTTCATGGATA-3′, within intron 4; reverse primer: 5′-AGGAGTAGAGGCAGACAGAGAAAGA-3′, within the fifth exon of Ltbp1 genomic sequence and MGB probe: 5′-6FAM-TAAGCTGATGTGTTTGTTG-3′-MGBNFQ) and mouse β2-microglobulin (Mm00437762_m1). Realtime analysis was performed in the Applied Biosystems ViiA™ 7. Total Ltbp1, Ltbp1L and 1S mRNA levels were normalized to those of mouse β2-microglobulin and plotted as levels relative to tissue from 12-week-old virgins.
Results
Ltbp1L-LacZ expression underlies a route for axillary cell migration and is an early marker of the mammary mesenchyme
We utilized an Ltbp1L lz/+ reporter mouse (Figure 1) in an attempt to understand potential physiological roles of LTBP1L [20] . Mammary development begins in mice at E10.5 with the formation of ectodermal ridges between the limbs, termed mammary lines that fragment to form placodes 3 and 4 [46] . Although Ltbp1L-LacZ expression was found between the limbs at this stage in Ltbp1L lz/+ embryos (Figure 2A black arrow), in sections it localized principally to internal viscera ( Figure 2B black arrow) . Robust Ltbp1L-LacZ expression first appeared at E11.5 to E12.0 in a subaxillary mesenchymal streak ( Figure 2C and D, white arrow) abutting mammary placodes 1 and 2 ( Figure 2C, red arrows) . Intriguingly, ectodermal cells have been shown to migrate along a similar path to form pectoral and thoracic placodes 1 to 3 [47] . Later Ltbp1L-LacZ became intensely expressed around all five buds ( Figure 3A -C) and colocalized with well-characterized mammary mesenchyme markers, such as androgen receptor (AR), estrogen receptor (ER), tenascin C and lymphoid enhancer-binding factor 1 (Lef1) ( Figure 3D -G) [46] . Thus, during early embryonic mammary development Ltbp1L expression underlies a migratory route for epithelial cells and is one of the earliest markers of the inductive mammary mesenchyme.
Mesenchymal Ltbp1L activity accompanies nipple induction and persists in smooth-muscle cells and myofibroblasts in the adult
In males, stimulation of androgen receptors at E14.5 induces mammary mesenchymal constriction and atrophy leading to bud loss and failure of nipple formation [48] . In contrast, in females, mammary mesenchyme signaling induces ductal morphogenesis, differentiation of nipple epithelium and suppression of hair follicles within the areola [49] . Reflecting this sexual dimorphism, Ltbp1L-LacZ expression was diminished in E14.5 males ( Figure 3B ) and lost by E15.5 but was maintained in females ( Figure 3A) , and robustly expressed during nipple induction at E16.5 ( Figure 4A, B) . Once the nipple shield had formed, reporter expression became restricted to muscle cells of the areola (Figure 4C, D) .
Nipples undergo significant postnatal connective tissue remodeling. In virgin and early pregnant mice, the nipple, delimited by germinative epidermal ingrowths, encloses predominantly collagenous connective tissue. During late pregnancy, nipple stromal cells proliferate and synthesize elastin, leading to elastic fiber hypertrophy [50] . Ltbp1L-LacZ was strongly expressed in smooth muscle of the nipple sphincter, located at the base of the areola (Figure 5A-C) , which were surrounded by elastic fibers (Figure 5D ). Ltbp1L was silent within the nipple stroma at most developmental stages ( Figure 5A, G, H) . However, robust Ltbp1L reporter expression appeared briefly during mid-pregnancy P13.5 within vimentin-positive stromal cells ( Figure 5E, F) at the base of the lactiferous duct and directly adjacent to the clefting germinative epithelium. Thus the temporal-spatial expression of Ltbp1L appears coincident with the formation of the nipple sphincter and during elastin synthesis by stromal myofibroblasts.
Ltbp1L promoter activity coincides with ductal lumena formation within the embryonic mammary tree
At E16 mammary mesenchymal signaling induces proliferation of a solid cord of cells to form the mammary sprout [46, 49] . Ltbp1L remained silent within the epithelium at this stage ( Figure 4B ) but became robustly expressed at around E17.5, in luminal cells coincident with the appearance of microlumen ( Figure 6B, D) . Intriguingly, reporter expression was absent from the multilayered ductal tips (arrowheads, Figure 6E ) and from portions of the lactiferous duct within the nipple that comprise stratified epithelium ( Figure 6D ). Thus, Ltbp1L is induced only when the lactiferous duct enters the fat pad and differentiates into a bi-layered tube comprising a simple epithelial luminal lining surrounded by molecularly distinct basal cells.
Ltbp1 mRNA is dynamically modulated during postnatal development
Mammary development continues postnatally during puberty and is completed only after a first pregnancy. To determine if Ltbp1 was expressed during the postnatal period we isolated total RNA from mammary glands of virgin, pregnant and lactating mice as well as from those undergoing post-parous remodeling (involution), and performed qRT-PCR. Total Ltbp1 mRNA was expressed at modest levels in virgin mice, decreased during pregnancy, lost during lactation and robustly upregulated during early involution, peaking at day 3 and returning to that found in virgins after 5 to 7 days ( Figure 7A ). Ltbp1S and 1 L showed a similar trend, however Ltbp1L rose in a more pronounced fashion at day 3 ( Figure 7B ).
Ltbp1L is induced in ductal luminal cells and distinguishes them from alveolar lineages
To determine more precisely where the Ltbp1L promoter is activated during postnatal mammary development, we examined Ltbp1L-LacZ expression in whole mounts and histological sections. In pubertal mice a balance of proliferation and apoptosis within outer cap and inner multilayered body cells of the bulbous terminal end buds (TEBs) generates the permanent ductal tree and creates a lumen in the subtending ductal system. X-Gal-stained whole mounts revealed Ltbp1L-LacZ expression lining the lumen of the TEB ( Figure 7C ). Reporter expression was notably absent from the vast majority of body cells, which are considered to be actively proliferating luminal precursors ( Figure 7D ).
Ltbp1L-LacZ was expressed prominently in luminal cells of the permanent ductal system (Figure 8A Figure 8C bottom panel) , consistent with our observation of a punctate X-Gal staining pattern in some whole mounts ( Figure 8A ). Luminal cells can be further defined into mature and progenitor populations by their expression of CD61, a marker of integrin β3 that is highly expressed in luminal progenitors and Sca1 [51] . The majority of FDG + cells were Sca1 + ( Figure 8E ) and CD61 - (Figure 8F ), but a small percentage was CD61 + . Collectively these data indicate that Ltbp1L is induced in a subset of luminal progenitors and mature luminal cells of the permanent ductal system.
Pregnancy initially induces extensive arborization of the mammary ductal tree. Alveolar clusters form on the tip of each side-branch during mid-pregnancy and undergo secretory differentiation during late pregnancy in preparation for lactation. Mammary whole mounts taken during early, mid and late pregnancy showed Ltbp1L-LacZ expression throughout the permanent ductal system and within the newly developing transient side branches (Figure 9A-D) . In striking contrast, Ltbp1L remained silent within developing and differentiating alveoli throughout pregnancy (Figure 9C, D) . Histological sections through p16.5 alveolar clusters confirmed that Ltbp1L-LacZ expression was restricted to ducts and side branches (Figure 9E , F) and absent from alveolar milk-producing cells that contained large lipid droplets ( Figure 9F) . Thus Ltbp1L is a rare and highly specific marker distinguishing ductal from alveolar luminal lineages. 
Ltbp1L activity is dramatically upregulated during involution
During lactation luminal cells of both ducts and alveoli undergo secretory differentiation. Ltbp1L-LacZ expression was undetectable in whole mounts and sections at this stage ( Figure 10A, B ) consistent with the relative diminishment of Ltbp1 mRNA expression at this stage in qRT-PCR analysis (Figure 7A, B) . Milk stasis and ductal distension trigger an initial phase of involution involving cell death that is reversible if suckling resumes [37, 52] . After 48 h, however, involution proceeds irreversibly with collapse and removal of transient alveolar and side-branch structures. Throughout this process the permanent ductal system and resident stem cells are protected from destruction. Within 24 hours of pup weaning Ltbp1L-LacZ expression appeared along the main ducts and distended primary side branches ( Figure 10C, D) . In sections, the reporter expression appeared in a discontinuous pattern within a subset of luminal cells ( Figure 10D ) and was absent from alveoli, which remained morphologically distended. By 72 h, as the alveoli collapsed and were undergoing clearance, Ltbp1L-LacZ became robustly expressed within remaining luminal epithelia ( Figure 10E, F) . This sharp increase in LTBP1 expression around the transition to irreversible involution was confirmed by qRT-PCR where Ltbp1, 1 L and 1S mRNA peaked at 72 h ( Figure 7A, B ). Collectively these results show that both forms of Ltbp1 are transcriptionally regulated throughout mammary development in a highly dynamic temporal and spatial manner and are maximal during involution.
Ltbp1 and elastin encase the mammary ductal system
Having identified the spatial pattern of Ltbp1L promoter activity and expression levels of both Ltbp1 mRNAs we next sought to determine the localization of the secreted Ltbp1L protein. We first examined sections of involuting glands by immunofluorescence and found Ltbp1L localized in microfibrillar strands surrounding ducts ( Figure 10G ). Resorcin-fuchsin detected elastic fibers in a similar periductal organization ( Figure 10H ). We next examined Ltbp1L and elastin organization at earlier stages ( Figure 11 ). In pubertal glands SMA antibodies detected the basal cell layer of ducts ( Figure 11A layer of TEBs indicating that Ltbp1 is deposited in close apposition to differentiated myoepithelial cells ( Figure 11A-B ). Weak Ltbp1 staining was seen in a few body cells of the TEB. The ductal system was also encased by a thick mesh of elastic fibers detected by anti-tropoelastin ( Figure 11C ). The elastic fibers, however, localized more distantly from the basal cell layer than Ltbp1. In glands from pregnant mice, Ltbp1 surrounded both the permanent ductal system and temporary side branches but was absent from alveolar clusters ( Figure 11D ). In contrast elastic fibers were restricted to the permanent ductal system ( Figure 11E ).
Discussion
The importance of TGFβ signaling for mammary physiology and pathology has been well documented however the factors that regulate TGFβ presentation and activation are less well-understood [53] . Although LTBPs determine the spatial deposition of latent TGFβ and thus define the coordinates for its subsequent activation, surprisingly nothing is known about them in normal mammary gland. Here we show that Ltbp1 is dynamically and focally regulated throughout mammary development. The major findings of our study are that 1) Within the mammary epithelium, Ltbp1L is transcribed exclusively by ductal luminal cells and distinguishes them from the alveolar luminal lineage; 2) Ltbp1 protein and elastic fibers exclusively encase the ductal system; 3) Ltbp1L and 1S are upregulated during involution, a developmental window linked to high risk for breast cancer promotion; and 4) Ltbp1L is induced in mammary mesenchyme and sustained in the smoothmuscle cells of the nipple sphincter.
Ltbp1L is induced in embryonic mammary mesenchyme and persists in nipple sphincter cells Ltbp1L-LacZ is first expressed in an arc around the forelimb. This pattern is intriguing in light of reports that mammary precursors destined for placodes 1 to 3 migrate along a similar path [47] . It is well known that TGFβ signaling promotes EMT and motogenesis. Thus, Ltbp1L expression may designate a migratory route and potentially stimulate ectodermal cell migration by presenting a focal source of TGFβ. Ltbp1L is next upregulated in the specialized mammary mesenchyme, which plays a pivotal role in inducing mammary morphogenesis and specifying the embryonic nipple and areola [49] . To date there have been no reports of TGFβ involvement in these inductive processes, although other members of the TGFβ family, such as bone morphogenic protein (BMP)4, are known to play critical roles [54, 55] . We find that the expression of mammary mesenchymal markers remains unperturbed and embryonic mammary development proceeds normally in Ltbp1L lz/lz embryos, indicating that Ltbp1L is not essential for mammary mesenchyme specification or inductive function. These results do not, however, preclude the possibility that the products of Ltbp1S, which is expressed from an independent promoter, or other Ltbp genes may compensate [56] . Alternatively Ltbp1L may function at later stages in the differentiation of these cell types. Ltbp1L-LacZ expression persists within smooth muscle cells aligned in radial arrays under the areola, which facilitate nipple projection and regulate the nipple sphincter during milk let-down. There have been no studies on TGFβ in the nipple, however, misexpression of Wnt5a, a target gene of TGFβ, has been shown to impair milk ejection, supporting the concept that specific levels of TGFβ signaling may be critical for nipple function [57] . We also observe strong Ltbp1L-LacZ expression in myofibroblasts during mid-pregnancy when the stroma synthesizes elastin to provide structural support for the lactiferous duct [58] . Whether Ltbp1L functions to reinforce the surrounding elastic fibers, and/or serves in a mechanosensory capacity between TGFβ signaling and the establishment of the unique nipple stroma, remains to be determined. of ductal canalization. This specificity is maintained throughout pubertal development and pregnancy where it serves as a rare marker distinguishing ductal from alveolar luminal cells. Transplantation studies have suggested that ductal and alveolar progenitors are distinct, but little is known about differences between mature ductal and alveolar luminal cell-types [59] . Ltbp1L is active in approximately 65% of luminal cells but silent within the inner body cells of the TEB, which are thought to be a proliferative progenitor population. It is upregulated within mature CD61 -Sca1 + cells in the subtending duct and within a small subpopulation of CD61 + luminal progenitors, which we speculate may generate side branches during pregnancy. Previous studies have implicated TGFβ signaling in suppressing proliferation of luminal populations and maintaining the potency of basal stem cell populations [34, 36, 60] . Our results show that Ltbp1 protein is deposited in close apposition to basal cells encasing the ductal system and thereby positioning TGFβ to carry out these functions.
Ltbp1 and ductal cell fate
Ltbp1 in the physiology of ductal dilation and distension
The appearance of Ltbp1L-LacZ expression coincident with lumen formation in the embryonic mammary rudiment and in the pubertal TEB suggests Ltbp1 may position TGFβ to generate lumen by inducing apoptosis [61] . TGFβ is a well-known pro-apoptotic cytokine and multiple studies have demonstrated a role for apoptotic factors in lumen formation in vitro and in vivo [34, 37] . However the periductal restriction of Ltbp1 protein in close association with elastic fibers makes this function unlikely and moreover indicates that they participate in some ductal versus alveolar specific process. lumenal diameter in a mechanosensory fashion remains to be determined.
Ltbp1L is silenced during lactation and dramatically induced during involution
The most dramatic changes in Ltbp1 activity occurred with the onset and cessation of lactation. Ltbp1, 1L and 1S mRNA were undetectable during lactation, and Ltbp1L-LacZ expression was lost even from the ducts as the entire epithelium assumed a secretory phenotype and the lumen became engorged with milk. This loss of Ltbp1L and 1S expression coincides with a change in the trafficking of latent TGFβ from basolateral secretion as a large latent complex destined for incorporation into the ECM in an Ltbp-dependent manner to apical secretion of small latent complex into milk, which functions to promote IgA production and induce oral tolerance in the newborn [62] .
Ltbp1L is dramatically induced during involution. Involution is a biphasic event, marked by distinct biological processes. For up to 48 h after weaning the process is reversible and characterized by alveolar apoptosis. After this point it becomes irreversible, as protease-mediated matrix remodeling leads to alveolar collapse and rebuilding of the ECM, to return the gland to a virgin-like state [63] . Teatsealing experiments have shown that ductal distension triggers involution even in the presence of circulating lactogenic hormones, highlighting the role of local factors [37] . Our results show that Ltbp1L and 1S are induced within 24 h and peak at day 3 of involution, remaining elevated for some days. This pattern is similar to that reported for TGFβ3 in several microarray studies [64, 65] . TGFβ3 is upregulated 6-fold within 3 h of weaning and has been implicated as a local factor triggering alveolar apoptosis, however, the mechanism for its activation has not been studied [37] . Whether Ltbp1 is expressed early enough to facilitate TGFβ3's role in apoptosis remains to be determined. The peak of Ltbp1 and TGFβ3 induction correlates with the transition to the irreversible stage of involution, suggesting that elevated TGFβ signaling may contribute to this transition. Little is known about the role of TGFβ3 in later involution, though it has been hypothesized to promote fibroblast migration and ECM generation based on the upregulation of wound healing and ECM genes that are targets of TGFβ signaling during this phase [17, 63, 65] . Alternatively, the localization of Ltbp1 protein along ducts suggests it may function to protect the permanent ductal system and its ductal stem cells from destruction by integrating integrin and TGFβ signaling, which promote cell survival and stem cell potency, respectively [66] . Lastly, our finding that Ltbp1 expression is dramatically elevated during involution, when taken collectively with the fact that LTBP1 appears in two metastatic signatures [5, 6] and regulates TGFβ, a factor inducing EMT, suggests that LTBP1 may be a prometastatic element in pregnancy-associated breast cancer (PABC). Detected postpartum, PABC is highly aggressive and this feature is thought to result from the action of prometastatic factors in the microenvironment of involuting glands [67] . Thus LTBP1 levels may be worthy of investigation as a risk factor.
Conclusions
In conclusion, our results establish that Ltbp1 is dynamically regulated during mammary development. The pattern of Ltbp1L activity and Ltbp1 protein localization suggest roles in reinforcing elastic support and mechanosensory feedback for mammary ducts and nipple. Currently nothing is known of the role of this important TGFβ regulator in human breast. Its elevation during involution suggests LTBP1 is worthy of further investigation as a prometastatic candidate in PABC.
